E I Dupont de Nemours & Company v Imperial Chemical Industries Plc

The case of E I Dupont de Nemours & Company v Imperial Chemical Industries Plc was heard by the Full Court of the Federal Court of Australia. The dispute centred around patent opposition proceedings where the respondent, Imperial Chemical Industries Plc, opposed the applicant's patent application for a process related to the manufacture of fluorocarbons. The opposition was ultimately dismissed, but the costs awarded in the opposition proceeding and on appeal were contested.

The legal issues before the court involved the proper assessment of costs in patent opposition proceedings and the subsequent appeal, specifically whether the costs awarded were appropriate under the circumstances. The court had to consider the conduct of the parties, the complexity of the issues, and the outcomes of both the opposition and the appeal. The primary focus was on whether the costs ordered by the delegate of the Commissioner of Patents and the subsequent appeal costs were just and equitable.

The court found that the costs awarded by the delegate were not appropriate given the outcome of the opposition proceedings, where the applicant successfully defended the patent application. The court also considered the appeal, noting that the appeal was partially successful, and thus a proportional costs order was appropriate. The court held that the respondent should pay 60% of the applicant's costs for the appeal, including reserved costs, reflecting the partial success of the appeal. The order as to costs made by the delegate was set aside, and a new order was made in favour of the applicant.

The final orders of the court were that the costs order made by the delegate of the Commissioner of Patents be set aside and replaced with an order that the respondent pay the applicant's costs of the opposition proceeding. Additionally, the respondents were ordered to pay 60% of the applicant's costs of the appeal, including reserved costs. This decision provided clarity on the appropriate allocation of costs in patent opposition and appeal proceedings, ensuring that the costs reflect the outcomes and the conduct of the parties involved.